首页|血液灌流联合连续性静脉-静脉血液滤过对脓毒症合并急性肾损伤患者APACHEⅡ评分及血清炎性因子水平的影响

血液灌流联合连续性静脉-静脉血液滤过对脓毒症合并急性肾损伤患者APACHEⅡ评分及血清炎性因子水平的影响

扫码查看
目的:探讨血液灌流(Hemoperfusion,HP)联合连续性静脉-静脉血液滤过(Continuous veno-venous hemofiltration,CVVH)治疗脓毒症合并急性肾损伤(Acute kidney injury,AKI)的疗效,并分析其对急性生理学与慢性健康状况评分系统Ⅱ(Acute physiology and Chronic Health status score System Ⅱ,APACHEⅡ)评分、血清炎性因子水平的影响.方法:选取 2021 年2 月至2023 年2 月于本院诊治的 92 例脓毒症合并AKI患者为研究对象,分为对照组(CVVH治疗)、研究组(HP联合CVVH治疗),每组各 46 例.治疗7 d后对比两组临床疗效.治疗前、治疗 7 d后对比两组APACHEⅡ评分.治疗前、治疗 7 d后,采用IE33 彩色多普勒超声诊断仪检测肾血流指标水平,采用 PUZS-600A 全自动生化分析仪检测肾功能指标水平,采用 ELISA 法检测血清白细胞介素-6(Interleukin-6,IL-6)、血管细胞黏附因子-1(Vascular cell adhesion molecule-1,VCAM-1)、降钙素原(Procalcitonin,PCT)水平,采用免疫比浊法检测血清超敏C反应蛋白(Hypersensitive C-reactive protein,hs-CRP)水平,采用qRT-PCR法检测外周血单核细胞中Toll样受体(Toll-like receptor,TLRs)通路相关因子Toll样受体-2(Toll-like receptor-2,TLR-2)、Toll样受体-4(Toll-like receptor-4,TLR-4)、细胞核因子κB(Nuclear factor κB,NF-κB)水平.结果:研究组总有效率高于对照组(P<0.05);治疗后,研究组APACHEⅡ评分低于对照组,EDV、PSV高于对照组(P<0.05);治疗后,研究组血清 Scr、CysC、hs-CRP、IL-6、VCAM-1、PCT 及外周血 TLR-2、TLR-4、NF-κB mRNA水平低于对照组,肾胺酶水平高于对照组(P<0.05).结论:HP联合CVVH治疗脓毒症合并AKI的疗效确切,可有效控制病情进展,改善肾血流、肾功能,减轻机体炎性损伤,可能与抑制TLRs通路活化有关.
Effects of hemoperfusion combined with continuous venovenous hemofiltration on APACHEⅡ score and serum inflammatory factor levels in patients with sepsis complicated with acute kidney injury
Objective:To investigate the efficacy of hemoperfusion(HP)combined with continuous venovenous hemofiltration(CVVH)in the treatment of sepsis complicated with Acute kidney injury(AKI),and to analyze its effects on Acute Physiology and Chronic Health status score System Ⅱ(APACHEⅡ)and serum inflammatory factor levels.Methods:A total of 92 patients with sepsis combined with AKI treated in our hospital from February 2021 to February 2023 were selected as study subjects.All patients were divided into a control group(CVVH treatment)and a study group(HP combined CVVH treatment)by the odd-even grouping method,with 46 cases in each group.The clinical efficacy and APACHE Ⅱ scores of the two groups after 7 days of treatment were compared.Before and 7 days after treatment,the levels of renal blood flow indicators were measured using the IE33 color Doppler ultrasound diagnostic instrument,renal function indicators were measured using the PUZS-600A automatic biochemical analyzer,and serum levels of interleukin-6(IL-6),vascular cell adhesion molecule-1(VCAM-1),and procalcitonin(PCT)were measured using the ELISA method.Serum levels of hypersensitive C-reactive protein(hs-CRP)were detected using immunoturbidimetry,and Toll-like receptor(TLRs)pathway-related factors,such as Toll-like receptor-2(TLR-2),Toll-like receptor-4(TLR-4),and nuclear factors-κB(NF-κB)were detected in peripheral blood monocytes by qRT-PCR method.Results:The total effective rate of the study group was higher than that of the control group(P<0.05).After treatment,the APACHEⅡ score of the study group was lower than that of the control group,and the EDV and PSV were higher than that of the control group(P<0.05).After treatment,serum levels of Scr,CysC,hs-CRP,IL-6,VCAM-1,and PCT in the study group were lower than those in the control group,and renal aminase levels were higher than those in the control group(P<0.05).After treatment,the mRNA levels of TLR-2,TLR-4,and NF-κB in the peripheral blood of the study group were lower than those of the control group(P<0.05).Conclusion:HP combined with CVVH is effective in the treatment of sepsis complicated with AKI,which can effectively control the progression of the disease,improve the renal blood flow and kidney function,and reduce the inflammatory injury of the body,which may be related to inhibiting the activation of TLRs pathway.

SepsisAcute kidney injuryHemoperfusionContinuous veno-venous hemofiltrationInflammatory factor

许鹏鸽、茹幸蕊、黄海燕

展开 >

河南科技大学第一附属医院血液净化科,河南 洛阳 471000

脓毒症 急性肾损伤 血液灌流 连续性静脉-静脉血液滤过 炎性因子

2024

四川生理科学杂志
四川省生理科学会

四川生理科学杂志

影响因子:0.575
ISSN:1671-3885
年,卷(期):2024.46(6)